Search for Clinical Trial Results
Lymphoma, T-Cell, Cutaneous - 27 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL) Condition: Cutaneous T Cell Lymphoma Date: 2012-07-15 Interventions:
|
Completed |
Study Name: Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma Condition: Cutaneous T-Cell Lymphoma Date: 2006-03-23 Interventions:
|
Completed |
Study Name: A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL) Condition: Cutaneous T-cell Lymphoma Date: 2005-03-24 Interventions: Drug: romidepsin (depsipeptide, FK228) Study patients received romidepsin at a dose of 14 mg/m^2 intrave |
Recruiting |
Study Name: Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL) Condition: Cutaneous T-Cell Lymphoma Date: 2015-10-29 Interventions: Biological: IPH4102 |
Recruiting |
Study Name: Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL) Condition: Cutaneous T Cell Lymphoma Date: 2015-09-06 Interventions: Drug: dimethylfumarate dose escalation from 30 mg/d to 720 mg/d over 9 weeks following a preset design i |
NOT_YET_RECRUITING |
Study Name: A Safety Study of SGN-35T in Adults With Advanced Cancers Condition: Lymphoma, T-Cell, Cutaneous Date: 2024-05-18 Interventions: Given into the vein (IV; intravenously) |
RECRUITING |
Study Name: Tissue Repository: CTCL Collection Protocol Condition: Lymphoma, T-Cell, Cutaneous Date: 2024-05-18 |